UNSPSC 51152004: Vecuronium

This classification denotes a nicotinic antagonist with the molecular formula C34H57N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5438723848, chemically known as 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate but generally known as vecuronium, which bears US NIH Compound Identifier 39764. European Medicines Agency schedules Vecuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05084MIG.

UNSPSC 51152004 Vecuronium is a Commodity code for a specific pharmaceutical agent, but state and local procurement activity under this code shows a marked mismatch: the two recent opportunities logged against it involve naloxone procurement and direct-to-manufacturer prescription programs, neither of which align with vecuronium's scope as a neuromuscular blocking agent used in anesthesia and critical care. Seminole County, Florida's IFB60459723LAS solicitation (posted June 30, 2026, response due July 26, 2023) sought 1,900 units of naloxone annually for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building and all shipping included in vendor pricing. The Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) was an exploratory information-gathering exercise on direct-to-manufacturer prescription programs and vendor capacity to contract outside traditional pharmacy benefit manager and wholesaler channels—neither of these reflects actual vecuronium purchasing intent. The code shows no documented state or local procurement activity directly tied to vecuronium supply, acquisition, or distribution.

Given the absence of relevant recent opportunities, the code does not support a clear characterization of issuing-body type, geographic concentration, or scope of work as actually bought under this Commodity designation. The two opportunities recorded against UNSPSC 51152004 are unrelated pharmaceutical and pharmacy program activities, suggesting either a data-tagging error or that vecuronium procurement through state and local bodies is minimal or nonexistent in the current market. A firm evaluating this code should verify whether state and local purchasing actually occurs under this specific commodity number and whether it warrants active pursuit relative to broader pharmaceutical or medical-supply categories.